Advertisement
Advertisement
ALUR
Allurion Technologies, Inc.
1.11
USDSponsored
+0.04
+3.74%
Feb 06, 15:52 UTC -5
Closed
After-Market
1.09
-0.02
-1.35%
ALUR Earnings Reports
Positive Surprise Ratio
ALUR beat 5 of 7 last estimates.
71%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Allurion Technologies, Inc. earnings per share and revenue
On Jan 12, 2026, ALUR reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.73 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 2.96 million, with a --% difference. The market reacted with a +9.52% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
FAQ
What were Allurion Technologies, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Allurion Technologies, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Allurion Technologies, Inc.'s Q4 2025 earnings?
The stock price moved up 9.52%, changed from $1.68 before the earnings release to $1.84 the day after.
When is Allurion Technologies, Inc. expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Allurion Technologies, Inc.'s next earnings report?
Based on --
analysts, Allurion Technologies, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement